NMP in Relapsed / Refractory Myeloma

Clinical trial NCT02468687 · COMPLETED

Trial details

NCT number: NCT02468687
Sponsor: Peter MacCallum Cancer Centre, Australia
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2015-08-20
Primary completion: 2021-10-07
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.